
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CALCIBIND | Mission Pharmacal | N-018757 DISCN | 1982-12-28 | 2 products |
Brand Name | Status | Last Update |
|---|---|---|
| bio skin crystal bio-cellulose mask | OTC monograph final | 2015-09-23 |
| hankki ssog pre-biome shake (detox and diet shake) | unapproved drug other | 2025-05-28 |
| lacrisert | New Drug Application | 2024-07-25 |
| limulus bio cellulose mask | unapproved drug other | 2017-06-28 |
| miracle of skin | unapproved drug other | 2018-03-23 |
| optase allegro | C200263 | 2024-12-17 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 30 | 7 | 3 | 2 | 55 | 93 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 3 | 11 | 3 | 8 | 28 | 52 |
| Overweight | D050177 | — | E66.3 | 2 | 3 | 3 | 1 | 31 | 39 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 4 | 15 | 6 | 2 | 13 | 38 |
| Syndrome | D013577 | — | — | 3 | 11 | 4 | 5 | 19 | 38 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 4 | 12 | 4 | 6 | 12 | 37 |
| Infections | D007239 | EFO_0000544 | — | 3 | 10 | 5 | 3 | 14 | 35 |
| Inflammation | D007249 | MP_0001845 | — | 3 | 7 | 1 | 2 | 21 | 33 |
| Hypertension | D006973 | EFO_0000537 | I10 | 2 | 4 | — | 5 | 15 | 25 |
| Prediabetic state | D011236 | EFO_1001121 | R73.03 | 2 | 1 | — | 2 | 21 | 25 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Covid-19 | D000086382 | — | U07.1 | 4 | 13 | 8 | — | 3 | 23 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 1 | 8 | 2 | — | 13 | 22 |
| Communicable diseases | D003141 | — | — | 1 | 6 | 3 | — | 11 | 21 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 6 | 4 | 4 | — | — | 14 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | 4 | 5 | 2 | — | 4 | 14 |
| Respiratory tract infections | D012141 | — | J06.9 | — | 2 | 3 | — | 9 | 14 |
| Glucose intolerance | D018149 | HP_0000833 | R73.03 | 1 | 1 | 1 | — | 11 | 13 |
| Wounds and injuries | D014947 | — | T14.8 | 2 | 3 | 3 | — | 6 | 12 |
| Sleep | D012890 | GO_0030431 | — | — | 2 | 3 | — | 8 | 12 |
| Body weight | D001835 | EFO_0004338 | — | 1 | 1 | 1 | — | 10 | 12 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Fatigue | D005221 | — | R53.83 | 2 | 5 | — | — | 16 | 21 |
| Oxidative stress | D018384 | EFO_1001905 | — | 3 | 3 | — | — | 8 | 12 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 6 | 5 | — | — | 2 | 10 |
| Multiple sclerosis | D009103 | EFO_0003885 | G35 | 3 | 6 | — | — | 2 | 9 |
| Sclerosis | D012598 | — | — | 1 | 7 | — | — | 1 | 8 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 3 | — | — | 5 | 8 |
| Cocaine-related disorders | D019970 | — | F14 | 2 | 7 | — | — | — | 8 |
| Gastrointestinal microbiome | D000069196 | — | — | 3 | 1 | — | — | 5 | 8 |
| Healthy aging | D000073656 | — | — | 1 | 1 | — | — | 5 | 7 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 2 | 2 | — | — | 4 | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sarcopenia | D055948 | EFO_1000653 | M62.84 | 1 | — | — | — | 10 | 11 |
| Pharmacokinetics | D010599 | — | — | 5 | — | — | — | — | 5 |
| Crohn disease | D003424 | EFO_0000384 | K50 | 1 | — | — | — | 4 | 5 |
| Autism spectrum disorder | D000067877 | — | F84.0 | 1 | — | — | — | 4 | 5 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | 3 | — | — | — | 2 | 5 |
| Goiter | D006042 | EFO_0004283 | E04.9 | 1 | — | — | — | 3 | 4 |
| Lipid metabolism disorders | D052439 | — | — | 1 | — | — | — | 2 | 3 |
| Coronavirus infections | D018352 | EFO_0007224 | B34.2 | 2 | — | — | — | 1 | 3 |
| Colitis | D003092 | EFO_0003872 | K52.9 | 2 | — | — | — | 1 | 3 |
| Parasomnias | D020447 | — | G47.5 | 1 | — | — | — | 2 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Affect | D000339 | — | — | — | — | — | — | 8 | 8 |
| Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 7 | 7 |
| Psychological well-being | D000092862 | — | — | — | — | — | — | 5 | 5 |
| Surgical wound | D000072836 | — | — | — | — | — | — | 4 | 4 |
| Psychological stress | D013315 | — | — | — | — | — | — | 4 | 4 |
| Mental fatigue | D005222 | — | — | — | — | — | — | 4 | 4 |
| Alopecia | D000505 | — | L64 | — | — | — | — | 4 | 4 |
| Healthy diet | D000072001 | — | — | — | — | — | — | 4 | 4 |
| Postmenopause | D017698 | — | — | — | — | — | — | 3 | 3 |
| Pediatric obesity | D063766 | — | — | — | — | — | — | 3 | 3 |
| Drug common name | Powdered cellulose |
| INN | _ |
| Description | Lacrisert (microcrystalline cellulose) is an insert placed in the eye to treat moderate to severe dry eyes. It also can be used to treat the following eye conditions: exposure keratitis, decreased corneal sensitivity and recurrent corneal erosions. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL4297557 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | ZY7ZTE7LFH (ChemIDplus, GSRS) |





